KVK-Tech, Inc. has recalled 1,692 bottles of Atovaquone Oral Suspension (750 mg/5 mL) after receiving customer complaints about the product having an unusual gritty texture. This condition was caused by temperature abuse, where the medication was exposed to temperatures outside of its required storage range. Atovaquone is a prescription antibiotic medication used to treat or prevent certain types of pneumonia.
The unusual grittiness indicates that the medication has been compromised by improper temperature control, which may affect the product's quality or how it is absorbed. While no injuries have been reported, consumers should not use medication that has an abnormal texture or appearance.
You have 2 options:
Mfd. By: KVK-Tech, Inc., Newtown, PA 18940. Recall #: D-0772-2021.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.